ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,666Medicare Part D Prescriptions Filled, Including Refills

Rank: 224 out of 6645

$750K Total Retail Price of All Prescriptions

Rank: 563 out of 6645

1,063 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,063 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 1,063 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 15,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 1,181 1,091 1 3
FUROSEMIDE 881 826 2 11
LEVOTHYROXINE SODIUM 700 632 3 4
SIMVASTATIN 645 567 4 1
HYDROCODONE-ACETAMINOPHEN 608 531 S3 5 5
OMEPRAZOLE 593 510 6 6
AMLODIPINE BESYLATE 513 443 7 2
METOPROLOL TARTRATE 464 439 8 13
POTASSIUM CHLORIDE 378 351 9 28
HYDROCHLOROTHIAZIDE 347 261 10 9
ATENOLOL 319 266 11 8
LOVASTATIN 295 281 12 15
GABAPENTIN 286 258 13 18
METFORMIN HCL 258 225 14 7
CLOPIDOGREL 253 241 15 36
CARVEDILOL 223 199 16 25
ALENDRONATE SODIUM 222 212 17 14
SERTRALINE HCL 221 207 18 43
LANTUS 209 141 19 50
GLIPIZIDE 196 174 20 23
TAMSULOSIN HCL 195 188 21 22
ZOLPIDEM TARTRATE 186 151 22 17
DONEPEZIL HCL 176 176 23 27
PANTOPRAZOLE SODIUM 170 146 24 29
DIGOXIN 167 166 25 59
PLAVIX 167 148 25 49
DOXAZOSIN MESYLATE 146 146 27 81
WARFARIN SODIUM 144 137 28 16
ADVAIR DISKUS 141 127 29 45
INSULIN SYRINGE 138 102 30 61
SPIRIVA 137 132 31 65
LEVOFLOXACIN 124 115 32 83
ATORVASTATIN CALCIUM 123 102 33 10
CITALOPRAM HBR 122 96 34 35
NAMENDA 114 112 35 41
JANUVIA 112 107 36 38
CLONIDINE HCL 109 102 37 56
ESCITALOPRAM OXALATE 109 96 37 86
FAMOTIDINE 107 97 39 33
GEMFIBROZIL 107 65 39 96
AMIODARONE HCL 105 105 41 160
DIOVAN 104 89 42 19
PROMETHAZINE HCL 98 86 R 43 219
KLOR-CON 10 91 90 44 145
GLYBURIDE 89 88 R 45 58
HYDRALAZINE HCL 89 79 45 77
LOSARTAN POTASSIUM 88 87 47 12
PRAVASTATIN SODIUM 85 79 48 20
PROAIR HFA 84 63 49 32
TEMAZEPAM 82 79 50 269
PREDNISONE 79 63 51 57
TRAMADOL HCL 79 67 51 30
ISOSORBIDE MONONITRATE ER 77 77 53 66
ALLOPURINOL 77 76 53 31
CLONIDINE 75 69 55 308
ENALAPRIL MALEATE 73 73 56 75
CARISOPRODOL 72 40 R 57 94
LORAZEPAM 71 67 58 189
CRESTOR 70 51 59 34
CIPROFLOXACIN HCL 69 59 60 67
RANITIDINE HCL 67 56 61 51
NIFEDIPINE ER 63 54 62 82
BENAZEPRIL HCL 61 53 63 21
ALPRAZOLAM 60 53 64 195
METOPROLOL SUCCINATE 59 58 65 24
HUMALOG 57 32 66 137
TRAZODONE HCL 55 50 67 60
TRICOR 55 51 67 138
NIFEDIAC CC 55 54 67 231
FINASTERIDE 54 50 70 73
FENTANYL 53 51 S2 71 141
VERAPAMIL ER 53 46 71 154
PHENYTOIN SODIUM EXTENDED 51 37 73 172
TERAZOSIN HCL 51 49 73 48
FLUOXETINE HCL 50 47 75 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.